|1.||Ghaseminejad, Azizeh: 1 article (01/2015)|
|2.||Azmoodeh, Azra: 1 article (01/2015)|
|3.||Akbari Asbagh, Firouzeh: 1 article (01/2015)|
|4.||Hamzehgardeshi, Zeinab: 1 article (01/2015)|
|5.||Pejman Manesh, Mansoureh: 1 article (01/2015)|
|6.||Newcombe, J R: 1 article (02/2012)|
|7.||Cuervo-Arango, J: 1 article (02/2012)|
|8.||Malkawi, S: 1 article (08/2006)|
|9.||Diab, F: 1 article (08/2006)|
|10.||Balawneh, M: 1 article (08/2006)|
08/01/2006 - "The objective of this study was to determine the incidence and recurrence rate of luteinized unruptured follicle (LUF) syndrome in women with unexplained infertility undergoing intrauterine insemination (IUI). "
01/01/1992 - "A study was initiated to evaluate the prevalence of the luteinized unruptured follicle (LUF) syndrome in a group of 355 women with infertility. "
05/01/1991 - "This study suggests a high incidence of LUF when CC is administered to ovulatory patients, and its use in patients with ovulatory infertility is questioned."
01/01/2015 - "Luteinized unruptured follicle (LUF) syndrome is considered a cause of ovulation failure and a subtle cause of infertility. "
01/01/1990 - "This article reviews today's diagnostic possibilities, the occurrence of LUF in patients with different types of sterility, the etiology and therapeutic approaches."
01/01/1999 - "In summary, in this study we noted a significant increase in LUF frequency in endometriosis patients with ovarian involvement."
01/01/1999 - "When we review the current literature on endometriosis and luteinized unruptured follicle (LUF), we see that most of the studies deal with only the association between LUF frequency and the severity of endometriosis. "
08/01/1986 - "This study describes the variety of endocrinological abnormalities found in women with mild endometriosis, and concludes that, in this series at least, there is a low frequency of LUF."
01/01/1999 - "The LUF frequencies were 45.9% in 37 endometriosis patients with ovarian involvement, 9.5% in 21 cases without ovarian involvement, and 5.9% in 68 cases without endometriosis. "
01/01/1999 - "The prevalence of LUF in mild, moderate and severe endometriosis cases was 13.3, 41.2 and 72.7%, respectively. "
01/01/2002 - "Its inhibition is thought to cause luteinised unruptured follicle (LUF) syndrome, an anovulatory condition characterised by clinical signs of ovulation but in the absence of follicular rupture and ovum release. "
03/01/1996 - "The probability of follicular rupture was related to follicular diameter at 12 h before HCG administration; 6% of follicles < 12 mm in diameter ruptured compared with 87% of follicles 18-19 mm. A complete luteinized unruptured follicle (LUF) syndrome was observed in six cycles (20%). "
01/01/1990 - "Luteinization of a follicle without its rupture and without the oocyte being expelled which is also called the LUF-syndrome by English speaking authors is one of a number of functional abnormalities that can occur to the follicle in the ovary and is diagnosed by ultrasound methods. "
08/01/1989 - "Premature luteinization induces intrafollicular ovum retention without (LUF syndrome) or with follicular rupture. "
02/01/1987 - "In spontaneous cycles with a mid-luteal P level below 32 nmol/l (10 ng/ml) a luteinized unruptured follicle (LUF) was found in 71.1% of cycles, whereas in spontaneous cycles with a mid-luteal P level above 32 nmol/l only 7.9% cycles exhibited a failure of the follicle to rupture. "
07/01/1989 - "CT, performed 10 days after LUF injection, demonstrated HCC daughter tumors not depicted by US, conventional CT, and angiography, in 34% of the cases, and in 9% of the patients only CT/LUF was able to show HCC in clinically positive cases with no evidence of tumor on other imaging techniques. "
07/01/1989 - "Therefore LUF opacification can be used to demonstrate small daughter tumors not shown by CT or US in cases with evidence of HCC, or to diagnosis HCC in clinically positive patients with no evidence of tumor at non-invasive screening. "
04/01/1994 - "LUF has been shown to be taken up hepatocellular carcinoma and retained for a long period of time in the tumor bed. "
06/01/1987 - "[Distribution, accumulation and excretion of Lipiodol Ultra-Fluid (LUF) following intra-arterial administration into the tumor-free liver. "
08/01/1988 - "I-131 LUF concentrated in the tumor with a tumorous (T) to nontumorous (NT) activity ratio (T/NT) of 4.3 +/- 3.6 for hepatocellular carcinoma and 2.4 +/- 0.7 for hepatic metastases. "
|5.||Liver Neoplasms (Liver Cancer)
|1.||Ethiodized Oil (Ethiodol)
|2.||Antineoplastic Agents (Antineoplastics)
|3.||Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
|8.||Levonorgestrel (Plan B)
|1.||Absorbable Gelatin Sponge
|2.||Combination Drug Therapy (Combination Chemotherapy)